Ryan Sullivan
2018
Compensation breakdown
| Non-Equity Incentive Plan | $229,122 |
|---|---|
| Option Awards | $1,190,351 |
| Salary | $376,158 |
| Stock Awards | $1,239,112 |
| Other | $173,437 |
| Total | $3,208,180 |
Sullivan received $1.2M in stock awards, accounting for 39% of the total pay in 2018.
Sullivan also received $229.1K in non-equity incentive plan, $1.2M in option awards, $376.2K in salary and $173.4K in other compensation.
Rankings
In 2018, Ryan Sullivan's compensation ranked 3,597th out of 14,244 executives tracked by ExecPay. In other words, Sullivan earned more than 74.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,597 out of 14,244 | 75th |
Division Manufacturing | 1,329 out of 5,759 | 77th |
Major group Chemicals And Allied Products | 469 out of 2,122 | 78th |
Industry group Drugs | 388 out of 1,811 | 79th |
Industry Pharmaceutical Preparations | 299 out of 1,385 | 78th |
Pay ratio
| Ryan Sullivan's Pay | $3,208,180 |
|---|---|
| Median Employee's Pay | $244,883 |
| Pay Ratio | 13to 1 |
In 2018, the annual total compensation of Ryan Sullivan was $3,208,180.
The annual total compensation of the median employee at Intercept Pharmaceuticals was $244,883.
The ratio of Ryan Sullivan's pay to the pay of median employee was therefore 13 to one.
Sullivan's colleagues
We found four more compensation records of executives who worked with Ryan Sullivan at Intercept Pharmaceuticals in 2018.
2018
Mark Pruzanski
Intercept Pharmaceuticals
Chief Executive Officer
2018
Jerome Durso
Intercept Pharmaceuticals
Chief Operating Officer
2018
Gail Cawkwell
Intercept Pharmaceuticals
SVP, Medical Affairs, Safety & Pharmacovigilance
2018
Sandip Kapadia
Intercept Pharmaceuticals